SCHEMBL4408807

SCHEMBL4408807

COc1ccc(C(N)c2nc(-c3cccc4ncccc34)cnc2N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 3/20 0.45
BMP4 P12644 3/20 0.45
BMPR1B O00238 2/20 0.45
KDR P35968 2/20 0.45
BMPR1A P36894 2/20 0.45
ACVRL1 P37023 2/20 0.45
ACVR1 Q04771 2/20 0.45
ATR Q13535 1/20 0.45
ALDH1A1 P00352 1/20 0.39
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PDCD1 Q15116 2/20 0.37
CD274 Q9NZQ7 2/20 0.37
ROCK1 Q13464 1/20 0.37
RECQL P46063 1/20 0.37
ACVR1B P36896 1/20 0.37
TGFBR1 P36897 1/20 0.37
TGFBR2 P37173 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
AAK1 Q2M2I8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL481871 0.76 APP (0.52) SYKBMP4BMPR1BKDRBMPR1A
SCHEMBL481930 0.74 ATR (0.59) SYKACVR1ATRTGFBR1AAK1
SCHEMBL481965 0.71 ATR (0.56) ACVR1ATRTGFBR1AAK1HTT
SCHEMBL8027506 0.70 ACVR1 (0.60) SYKBMP4BMPR1BKDRBMPR1A
SCHEMBL481591 0.69 FYN (0.45) BMP4BMPR1BKDRBMPR1AACVRL1
SCHEMBL29504942 0.69 NPC1 (0.53) SYKBMP4BMPR1BKDRBMPR1A
SCHEMBL481496 0.69 ATR (0.49) ATRAAK1HTT
SCHEMBL481889 0.68 ATR (0.53) ATRALDH1A1AAK1
SCHEMBL2256520 0.67 ADORA2A (0.58) ALDH1A1ACACACYP1A1CYP1A2CYP1B1
SCHEMBL3114801 0.67 IDO1 (0.42) SYKKDRROCK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2457913-B1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith SIGNAL PHARM LLC (US) 2017-04-19 EP disclosed
EP-2090577-B1 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors SIGNAL PHARM LLC (US) 2017-04-05 EP disclosed
EP-2457913-A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith Signal Pharmaceuticals LLC (US) 2012-05-30 EP disclosed
EP-2090577-A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors Signal Pharmaceuticals LLC (US) 2009-08-19 EP disclosed
EP-2078016-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed